title: Evolution of lesions over 10 years in a patient with SLE: flowchart approach to the new International Society of Nephrology (ISN)/Renal Pathology Society (RPS) classification of lupus nephritis.
authors.affiliation: Department of Histopathology, Imperial College, Hammersmith Hospital, London, UK.
authors.forename: Victoria
authors.initials: V
authors.lastname: Elliot
authors.forename: Thomas
authors.initials: T
authors.lastname: Cairns
authors.forename: H Terence
authors.initials: HT
authors.lastname: Cook
mesh_terms: D000293:Adolescent; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000069059:Atorvastatin; D001707:Biopsy, Needle; D018450:Disease Progression; D005500:Follow-Up Studies; D006417:Hematuria / Q000209:etiology; D006538:Heptanoic Acids / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006949:Hyperlipidemias / Q000188:drug therapy / Q000209:etiology; D007070:Immunoglobulin A / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007678:Kidney Glomerulus / Q000648:ultrastructure*; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D008181:Lupus Nephritis / Q000145:classification / Q000188:drug therapy / Q000473:pathology* / Q000628:therapy; D008297:Male; D015388:Organelles / Q000648:ultrastructure; D010951:Plasma Exchange; D011758:Pyrroles / Q000627:therapeutic use; D012598:Sclerosis; D012720:Severity of Illness Index; D012985:Software Design
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007070:Immunoglobulin A; D007075:Immunoglobulin M; D007166:Immunosuppressive Agents; D011758:Pyrroles; D000069059:Atorvastatin